Alembic Settles Dementia Drug Patent Dispute With Novartis


Advertisement
by Kathy Jones on  June 16, 2012 at 10:35 PM Medico Legal News
  •   Print
  •   Share
  •   Comments
  •  Text 
Indian drug maker Alembic Pharmaceuticals revealed that it has settled a patent case with Novartis over Rivastigmine Tartrate capsules which are used in treating dementia.
 Alembic Settles Dementia Drug Patent Dispute With Novartis

The company said that it had partnered an American company, Breckenridge Pharmaceuticals, in settling the Paragraph IV patent litigation with Novartis.

Following this settlement, Alembic Pharmaceuticals said Novartis has given them the license to market the generic version of capsules before the date of the patent expiry.

Source-Medindia
Do you like this Report?
0

 Email Email  RSS Feeds RSS Feeds  Print this page Print  Save this page Save  Link Link  Syndicate Syndicate  Comments Comments 
 
Comment & Contribute
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  
If you have a question about health related issues, you can now post it in our Ask An Expert section on our community website Medwonders.com and get answers from our panel of experts.
X

Related Links

Medico Legal Related News

  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Archive
Date :
Category :
Keyword :
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
News Categories:  
Women's Health Center